Light therapy and fluvoxamine in the treatment of bipolar psychotic depression: A pilot study

Linda Franchini, Simone Ballan, Cristina Colombo, Enrico Smeraldi

Research output: Contribution to journalArticle

Abstract

Objective: The aim of the study is to evaluate the tolerability and efficacy of adjunctive light therapy in a sample of psychotically depressed bipolar inpatients treated with fluvoxamine pharmacotherapy. Method: 27 subjects affected by bipolar disorder and hospitalized for a major depressive episode with psychotic features were treated with fluvoxamine 300 mg either alone or in combination with light therapy. Light was administered daily in 30 minutes sessions and timed according to individual chronotypes. HDRS and DDERS were used to assess clinical changes over time. Results: After six weeks of treatment overall remission rate was 80.8% (HDRS

Original languageEnglish
Pages (from-to)166-173
Number of pages8
JournalClinical Neuropsychiatry
Volume6
Issue number4
Publication statusPublished - 2009

Fingerprint

Fluvoxamine
Phototherapy
Bipolar Disorder
Inpatients
Light
Drug Therapy
Therapeutics

Keywords

  • Bipolar disorder
  • Fluvoxamine
  • Light therapy
  • Psychotic depression

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Light therapy and fluvoxamine in the treatment of bipolar psychotic depression : A pilot study. / Franchini, Linda; Ballan, Simone; Colombo, Cristina; Smeraldi, Enrico.

In: Clinical Neuropsychiatry, Vol. 6, No. 4, 2009, p. 166-173.

Research output: Contribution to journalArticle

Franchini, Linda ; Ballan, Simone ; Colombo, Cristina ; Smeraldi, Enrico. / Light therapy and fluvoxamine in the treatment of bipolar psychotic depression : A pilot study. In: Clinical Neuropsychiatry. 2009 ; Vol. 6, No. 4. pp. 166-173.
@article{f4003e3fae404cf2a701ad12de4e9758,
title = "Light therapy and fluvoxamine in the treatment of bipolar psychotic depression: A pilot study",
abstract = "Objective: The aim of the study is to evaluate the tolerability and efficacy of adjunctive light therapy in a sample of psychotically depressed bipolar inpatients treated with fluvoxamine pharmacotherapy. Method: 27 subjects affected by bipolar disorder and hospitalized for a major depressive episode with psychotic features were treated with fluvoxamine 300 mg either alone or in combination with light therapy. Light was administered daily in 30 minutes sessions and timed according to individual chronotypes. HDRS and DDERS were used to assess clinical changes over time. Results: After six weeks of treatment overall remission rate was 80.8{\%} (HDRS",
keywords = "Bipolar disorder, Fluvoxamine, Light therapy, Psychotic depression",
author = "Linda Franchini and Simone Ballan and Cristina Colombo and Enrico Smeraldi",
year = "2009",
language = "English",
volume = "6",
pages = "166--173",
journal = "Clinical Neuropsychiatry",
issn = "1724-4935",
publisher = "Giovanni Fioriti Editore",
number = "4",

}

TY - JOUR

T1 - Light therapy and fluvoxamine in the treatment of bipolar psychotic depression

T2 - A pilot study

AU - Franchini, Linda

AU - Ballan, Simone

AU - Colombo, Cristina

AU - Smeraldi, Enrico

PY - 2009

Y1 - 2009

N2 - Objective: The aim of the study is to evaluate the tolerability and efficacy of adjunctive light therapy in a sample of psychotically depressed bipolar inpatients treated with fluvoxamine pharmacotherapy. Method: 27 subjects affected by bipolar disorder and hospitalized for a major depressive episode with psychotic features were treated with fluvoxamine 300 mg either alone or in combination with light therapy. Light was administered daily in 30 minutes sessions and timed according to individual chronotypes. HDRS and DDERS were used to assess clinical changes over time. Results: After six weeks of treatment overall remission rate was 80.8% (HDRS

AB - Objective: The aim of the study is to evaluate the tolerability and efficacy of adjunctive light therapy in a sample of psychotically depressed bipolar inpatients treated with fluvoxamine pharmacotherapy. Method: 27 subjects affected by bipolar disorder and hospitalized for a major depressive episode with psychotic features were treated with fluvoxamine 300 mg either alone or in combination with light therapy. Light was administered daily in 30 minutes sessions and timed according to individual chronotypes. HDRS and DDERS were used to assess clinical changes over time. Results: After six weeks of treatment overall remission rate was 80.8% (HDRS

KW - Bipolar disorder

KW - Fluvoxamine

KW - Light therapy

KW - Psychotic depression

UR - http://www.scopus.com/inward/record.url?scp=74849105009&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=74849105009&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:74849105009

VL - 6

SP - 166

EP - 173

JO - Clinical Neuropsychiatry

JF - Clinical Neuropsychiatry

SN - 1724-4935

IS - 4

ER -